“Palonosetron, Second Generation 5-HT3 Antagonist: A New Perspective in CINV Management”. Hematology Meeting Reports 2, no. 7 (June 8, 2009). Accessed August 8, 2025. https://journals.pagepress.org/hmr/article/view/414.